[go: up one dir, main page]

TR199800001T1 - Makrolidler. - Google Patents

Makrolidler.

Info

Publication number
TR199800001T1
TR199800001T1 TR1998/00001T TR9800001T TR199800001T1 TR 199800001 T1 TR199800001 T1 TR 199800001T1 TR 1998/00001 T TR1998/00001 T TR 1998/00001T TR 9800001 T TR9800001 T TR 9800001T TR 199800001 T1 TR199800001 T1 TR 199800001T1
Authority
TR
Turkey
Prior art keywords
chain
macrocyclic
acid residue
positions
macrolides
Prior art date
Application number
TR1998/00001T
Other languages
English (en)
Turkish (tr)
Inventor
Fehr Theodor
Oberer Lukas
Quesniaux Ryffel Valerie
Sanglier Jean-Jaques
Schuler Walter
Sedrani Richard
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9513596.8A external-priority patent/GB9513596D0/en
Priority claimed from GBGB9515495.1A external-priority patent/GB9515495D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR199800001T1 publication Critical patent/TR199800001T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06052Val-amino acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
TR1998/00001T 1995-07-04 1996-07-04 Makrolidler. TR199800001T1 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9513596.8A GB9513596D0 (en) 1995-07-04 1995-07-04 Organic compounds
GBGB9515495.1A GB9515495D0 (en) 1995-07-28 1995-07-28 Organic compounds

Publications (1)

Publication Number Publication Date
TR199800001T1 true TR199800001T1 (xx) 1998-04-21

Family

ID=26307320

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00001T TR199800001T1 (xx) 1995-07-04 1996-07-04 Makrolidler.

Country Status (17)

Country Link
EP (1) EP0836616A1 (xx)
JP (1) JPH11509092A (xx)
KR (1) KR19990028724A (xx)
CN (1) CN1193979A (xx)
AR (1) AR006514A1 (xx)
AU (1) AU708004B2 (xx)
BR (1) BR9609324A (xx)
CA (1) CA2224715A1 (xx)
CO (1) CO4750713A1 (xx)
CZ (1) CZ424297A3 (xx)
HU (1) HUP9802320A3 (xx)
IL (1) IL122844A0 (xx)
NO (1) NO980016L (xx)
PL (1) PL324346A1 (xx)
SK (1) SK498A3 (xx)
TR (1) TR199800001T1 (xx)
WO (1) WO1997002285A1 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6124453A (en) * 1995-07-04 2000-09-26 Novartis Ag Macrolides
GB9811854D0 (en) * 1998-06-02 1998-07-29 Ciba Geigy Ag Organic compounds
US7368423B1 (en) * 2001-12-05 2008-05-06 The Scripps Research Institute Composition and method for treating chronic allograft rejection
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
AR054778A1 (es) 2005-06-17 2007-07-18 Novartis Ag Uso de sangliferina en hcv
US8067024B2 (en) 2006-02-10 2011-11-29 Medtronic Vascular, Inc. Medical devices to prevent or inhibit restenosis
CN101289440B (zh) * 2007-06-29 2010-08-25 中国热带农业科学院热带生物技术研究所 一种多烯大环类化合物及其制备方法与应用
WO2010034243A1 (en) * 2008-09-24 2010-04-01 Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences Novel gene cluster
EP2533784B1 (en) 2010-02-09 2015-04-22 Neurovive Pharmaceutical AB Sanglifehrin based compounds
WO2011098808A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
WO2011098805A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
GB201008123D0 (en) 2010-05-17 2010-06-30 Biotica Tech Ltd Novel compounds
AR084217A1 (es) 2010-12-10 2013-05-02 Gilead Sciences Inc Inhibidores macrociclicos de virus flaviviridae
CA2822347C (en) * 2010-12-20 2019-11-05 Neurovive Pharmaceutical Ab Sanglifehrin derivatives and methods for their production
JO3063B1 (ar) 2011-03-29 2017-03-15 Neurovive Pharmaceutical Ab مركب مبتكر وطرق لانتاجه
GB201118334D0 (en) 2011-10-24 2011-12-07 Biotica Tech Ltd Novel dosage form
SG11201408047XA (en) * 2012-06-08 2015-01-29 Gilead Sciences Inc Macrocyclic inhibitors of flaviviridae viruses
US9090653B2 (en) 2012-06-08 2015-07-28 Gilead Sciences, Inc. Macrocyclic inhibitors of flaviviridae viruses
AR091279A1 (es) 2012-06-08 2015-01-21 Gilead Sciences Inc Inhibidores macrociclicos de virus flaviviridae
WO2018091634A1 (en) 2016-11-18 2018-05-24 Neurovive Pharmaceutical Ab Use of sanglifehrin macrocyclic analogues as anticancer compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318144D0 (en) * 1993-09-01 1993-10-20 Sandoz Ltd Organic compounds
WO1995015328A1 (en) * 1993-11-30 1995-06-08 Abbott Laboratories Macrocyclic immunomodulators with novel cyclohexyl ring replacements

Also Published As

Publication number Publication date
EP0836616A1 (en) 1998-04-22
NO980016L (no) 1998-03-02
WO1997002285A1 (en) 1997-01-23
AR006514A1 (es) 1999-09-08
CO4750713A1 (es) 1999-03-31
CA2224715A1 (en) 1997-01-23
PL324346A1 (en) 1998-05-25
CZ424297A3 (cs) 1998-04-15
AU6519396A (en) 1997-02-05
MX9800217A (es) 1998-07-31
KR19990028724A (ko) 1999-04-15
SK498A3 (en) 1998-07-08
HUP9802320A3 (en) 1999-03-29
AU708004B2 (en) 1999-07-29
JPH11509092A (ja) 1999-08-17
HUP9802320A2 (hu) 1999-02-01
CN1193979A (zh) 1998-09-23
BR9609324A (pt) 1999-05-25
IL122844A0 (en) 1998-08-16
NO980016D0 (no) 1998-01-02

Similar Documents

Publication Publication Date Title
TR199800001T1 (xx) Makrolidler.
DE69411625D1 (de) Benzofuranyl- und Thiophenylalkancarbonsäurederivate
AU8241791A (en) Tagged polymers and synthesis thereof by post-polymerization (trans)amidation reaction
ATE236128T1 (de) N-alkylacridancarboxylderivate, geeignet für die detektion von chemilumineszenz
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
WO1998024802A3 (en) Compound
TR199800624T1 (xx) Yeni 5-0- deosaminil 6-0-metil eritronolid a t�revleri, bunlar�n kullan�m�.
TR199801039T2 (xx) Yeni fenilamidin t�revlerinin elde edilmesine y�nelik usul.
BR9712019A (pt) Derivados de cidos hirox-mico citoest ticos
MY111439A (en) Thymosin alpha 1 derivatives
ITMI910380A1 (it) Composti steroidei attivi sul sistema cardiovascolare
TR200401307T4 (tr) Alfa - (2-4-Disulfofenil) N-Ter-Bütilniron ve bunların farmasötik olarak kabul edilebilen tuzları için proses
EP0713702A4 (en) ANXIOLYTIC ACTIVE SUBSTANCE
TR199901956T2 (xx) 4H-4-Okso-kinolizin-3-karboksilik asit t�revlerinin haz�rlanmas� i�in bir i�lem.
ES2175228T3 (es) Metilsulfomicina i, un procedimiento para su produccion y su uso.
ES2155350A1 (es) Procedimiento de prepacion de un antibiotico de cefalosporina oralmente activo, cefixime.
TR199900532T2 (xx) Nizatidin haz�rlanmas� i�in y�ntem.
JPS6468389A (en) Novel n-acetyl-beta-d-glucosamine derivative
DK0623678T3 (da) Norbornantype-ester-hydrolase
JPS5718613A (en) Cholagogue
EP0684253A4 (en) DESALANINE LEVEL ANOMICIN A DERIVATIVES AND PRODUCTION THEREOF.
ES8507121A1 (es) Procedimiento para la obtencion de un derivado del benzofurazano
DE69019573D1 (de) Luciferinderivate.
TH29525B (th) ฟีนิลซับสทิทิวเท็ด 4-เอซาสเตียรอยด์ ฟลูออโรเดอริเวทีฟ
JPS543074A (en) Novel peptide derivative